Fennec Pharmaceuticals: chief strategy officer Christiana Cioffi received 3,946 shares

What happened The filing says Christiana Marie Cioffi, chief strategy officer, received 3,946 shares under the company's employee stock purchase plan at $5.53 per share on Oct 12, 2026, totaling $21,821.

Key details

• Transaction date and price: Oct 12, 2026; $5.53 per share; total $21,821.
• Transaction type/code: acquisition (code A) via the employee stock purchase plan (ESPP).
• ESPP period: Apr 9, 2026 through Oct 12, 2026 (footnote F1).
• Purchase pricing: per footnote F2, shares were purchased based on 85% of the closing price on Apr 9, 2026.
• Shares owned after the transaction: not reported in the filing.
• Filing date and timeliness: filed Oct 13, 2026; the filing is not marked late.

Why it may matter This was an acquisition under the employee stock purchase plan, not a market purchase or a sale. A filing does not show why the insider traded or why the company acted.